Long‐term follow‐up of <scp>VIALE‐A</scp>: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia
2024 · American Journal of Hematology · 177 citations
https://doi.org/10.1002/ajh.27246
C
Christian Récher
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.1K
Papers
25.8K
Citations
81
h-index
302
i10-index
Christian Récher is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Cancer, Lipids, and Metabolism. The author has an h-index of 81, co-authored 908 publications.
ORCID: 0000-0002-3332-4525Papers by this author
worksPhase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML
2014 · Cancer · 171 citations
https://doi.org/10.1002/cncr.28974
Follow-up of patients with R/R <i>FLT3-</i>mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial
2022 · Blood · 134 citations
https://doi.org/10.1182/blood.2021011583
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
2022 · The Lancet Haematology · 111 citations
https://doi.org/10.1016/s2352-3026(22)00292-7
Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort
2021 · Blood Advances · 107 citations
https://doi.org/10.1182/bloodadvances.2020003159
A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia
2015 · Blood Cancer Journal · 84 citations
https://doi.org/10.1038/bcj.2015.19
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat